Pharmaceutical Sector

Pfizer Makes Another Recall

Pfizer is reported to have widened the voluntary recall of its blockbuster cholesterol-fighting drug again. As per the company’s statement, an additional 38,000 bottles of the drug Lipitor have been recalled.

The decision emerged following reports that linked a "moldy or musty" odor with the packaging bottles, the Company highlighted. Pfizer had earlier given a recall for over 190,000 bottles of Lipitor because of similar kind of complaints.

General: 
Companies: 

Nuedexta Obtains FDA Approval; Avanir Shares More than Double

The Food and Drug Administration (FDA) recently approved Nuedexta, a drug that will treat bouts of uncontrolled laughter or crying in patients with neurological disorders. Avanir Pharmaceuticals Inc., the drug's maker, saw its shares more than double in extended trading.

General: 

Teflaro gets FDA Approval for CABP and ABSSI Treatment

On Friday, ceftaroline fosamil (Teflaro), manufactured by Forest Laboratories Inc. has been shown green signal by the Food and Drug Administration to provide treatment to adults suffering from community-acquired bacterial pneumonia (CABP) and other skin related infections such as acute bacterial skin and skin structure infections (ABSSSI) and methicillin-resistant Staphylococcus aureus (MRSA).

General: 

WeightWatchers Discard Outdated Diet Plan

The development taking place everyday has made the international dieting Company, p change its fat and calorie-based points plan. They are now said to have adopted the new system since the old plan has come out to be inaccurate and outdated.

As per this new system, the main focus is being laid on the amounts and types of protein, carbohydrate, fibre and fat in food. According to speculation, it also permits alcohol and the odd fast food binge.

General: 

Thalidomide Victims initiate Class Action against Grunenthal GmbH

German pharmacy Company Grunenthal GmbH is now sued by the Victorian Supreme Court for distributing the drug thalidomide to pregnant Australian women whose children developed inabilities after being born.

A number of plaintiffs who represent the victims of the harming substance want the firm to take responsibilities for severe violations more than 50 years ago.

General: 
Companies: 

Pages

Subscribe to RSS - Pharmaceutical Sector